Simon Hambidge
Concepts (331)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 42 | 2025 | 1381 | 3.130 |
Why?
| | Influenza Vaccines | 23 | 2025 | 539 | 2.860 |
Why?
| | Vaccines | 19 | 2025 | 406 | 2.710 |
Why?
| | Influenza, Human | 17 | 2024 | 622 | 2.040 |
Why?
| | Immunization | 8 | 2021 | 411 | 2.020 |
Why?
| | Immunization Programs | 10 | 2022 | 213 | 1.580 |
Why?
| | Pediatric Obesity | 10 | 2024 | 601 | 1.540 |
Why?
| | Adverse Drug Reaction Reporting Systems | 10 | 2023 | 77 | 1.290 |
Why?
| | Infant | 54 | 2025 | 9465 | 1.090 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 10 | 2017 | 91 | 1.080 |
Why?
| | Child Health Services | 5 | 2022 | 184 | 1.020 |
Why?
| | Measles-Mumps-Rubella Vaccine | 9 | 2021 | 42 | 1.010 |
Why?
| | Parents | 8 | 2021 | 1347 | 0.970 |
Why?
| | Child, Preschool | 48 | 2022 | 11074 | 0.910 |
Why?
| | Terminology as Topic | 2 | 2017 | 216 | 0.900 |
Why?
| | Chickenpox Vaccine | 9 | 2021 | 73 | 0.880 |
Why?
| | Attitude to Health | 3 | 2017 | 439 | 0.870 |
Why?
| | Cohort Studies | 38 | 2024 | 5742 | 0.780 |
Why?
| | Managed Care Programs | 5 | 2017 | 135 | 0.760 |
Why?
| | Counseling | 3 | 2017 | 391 | 0.730 |
Why?
| | Female | 95 | 2025 | 73304 | 0.720 |
Why?
| | Government Programs | 1 | 2021 | 25 | 0.710 |
Why?
| | Immunization Schedule | 5 | 2021 | 197 | 0.690 |
Why?
| | United States | 46 | 2025 | 14841 | 0.670 |
Why?
| | Colorado | 19 | 2017 | 4565 | 0.660 |
Why?
| | Information Storage and Retrieval | 3 | 2020 | 118 | 0.660 |
Why?
| | Child | 51 | 2025 | 21935 | 0.650 |
Why?
| | Vaccines, Combined | 5 | 2020 | 48 | 0.650 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1329 | 0.650 |
Why?
| | Humans | 121 | 2025 | 137585 | 0.650 |
Why?
| | Abortion, Spontaneous | 4 | 2025 | 105 | 0.640 |
Why?
| | Adolescent | 48 | 2025 | 21513 | 0.640 |
Why?
| | Whooping Cough | 5 | 2014 | 51 | 0.630 |
Why?
| | Reminder Systems | 2 | 2013 | 169 | 0.630 |
Why?
| | Male | 73 | 2025 | 67762 | 0.600 |
Why?
| | Language | 4 | 2017 | 292 | 0.590 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2025 | 394 | 0.590 |
Why?
| | Wounds and Injuries | 4 | 2008 | 758 | 0.590 |
Why?
| | Preventive Health Services | 2 | 2013 | 148 | 0.580 |
Why?
| | Pregnancy | 27 | 2025 | 6763 | 0.580 |
Why?
| | Population Surveillance | 9 | 2017 | 482 | 0.580 |
Why?
| | Seizures, Febrile | 5 | 2017 | 21 | 0.570 |
Why?
| | Pneumococcal Vaccines | 3 | 2022 | 142 | 0.560 |
Why?
| | Anemia, Sickle Cell | 2 | 2011 | 270 | 0.560 |
Why?
| | Vaccination Coverage | 3 | 2025 | 82 | 0.550 |
Why?
| | Urban Population | 5 | 2016 | 479 | 0.540 |
Why?
| | School Health Services | 4 | 2014 | 238 | 0.520 |
Why?
| | Vulnerable Populations | 2 | 2009 | 163 | 0.520 |
Why?
| | Safety-net Providers | 4 | 2021 | 119 | 0.490 |
Why?
| | Dental Caries | 1 | 2017 | 155 | 0.490 |
Why?
| | Seizures | 3 | 2014 | 426 | 0.480 |
Why?
| | Oral Health | 1 | 2017 | 124 | 0.480 |
Why?
| | Chickenpox | 2 | 2020 | 83 | 0.460 |
Why?
| | Emergency Service, Hospital | 6 | 2014 | 2069 | 0.460 |
Why?
| | Young Adult | 29 | 2025 | 13209 | 0.460 |
Why?
| | Incidence | 18 | 2024 | 2804 | 0.450 |
Why?
| | Body Mass Index | 6 | 2024 | 2389 | 0.450 |
Why?
| | Retrospective Studies | 36 | 2024 | 15657 | 0.440 |
Why?
| | Office Visits | 2 | 2007 | 93 | 0.440 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2014 | 10 | 0.440 |
Why?
| | Hospitalization | 6 | 2020 | 2199 | 0.420 |
Why?
| | Adult | 40 | 2025 | 37929 | 0.420 |
Why?
| | Product Surveillance, Postmarketing | 6 | 2022 | 63 | 0.420 |
Why?
| | Case-Control Studies | 14 | 2025 | 3556 | 0.410 |
Why?
| | Primary Health Care | 6 | 2021 | 1738 | 0.410 |
Why?
| | Papillomavirus Vaccines | 1 | 2016 | 238 | 0.410 |
Why?
| | Bronchiolitis | 1 | 2014 | 80 | 0.410 |
Why?
| | Infant, Newborn | 19 | 2025 | 6079 | 0.410 |
Why?
| | Pertussis Vaccine | 2 | 2011 | 22 | 0.400 |
Why?
| | Genes, MHC Class II | 1 | 2012 | 74 | 0.390 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2014 | 157 | 0.390 |
Why?
| | Weight Reduction Programs | 2 | 2024 | 117 | 0.380 |
Why?
| | Health Promotion | 2 | 2023 | 741 | 0.380 |
Why?
| | Treatment Refusal | 2 | 2010 | 89 | 0.370 |
Why?
| | Delivery of Health Care | 2 | 2017 | 951 | 0.370 |
Why?
| | Rotavirus Vaccines | 3 | 2022 | 46 | 0.360 |
Why?
| | Health Services Research | 2 | 2012 | 404 | 0.360 |
Why?
| | Vaccines, Inactivated | 4 | 2012 | 68 | 0.340 |
Why?
| | Health Personnel | 1 | 2017 | 710 | 0.340 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 48 | 0.330 |
Why?
| | Communication Barriers | 1 | 2011 | 104 | 0.330 |
Why?
| | Meningococcal Vaccines | 3 | 2017 | 55 | 0.330 |
Why?
| | Immunization, Secondary | 3 | 2025 | 87 | 0.320 |
Why?
| | Risk Assessment | 12 | 2020 | 3457 | 0.320 |
Why?
| | Urban Health | 2 | 2006 | 92 | 0.310 |
Why?
| | Case Management | 1 | 2009 | 66 | 0.310 |
Why?
| | Health Services Accessibility | 4 | 2011 | 986 | 0.300 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2022 | 91 | 0.290 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 15 | 0.290 |
Why?
| | Congenital Abnormalities | 3 | 2017 | 92 | 0.280 |
Why?
| | Insurance, Health | 3 | 2012 | 283 | 0.280 |
Why?
| | Middle Aged | 23 | 2025 | 33479 | 0.280 |
Why?
| | Anaphylaxis | 3 | 2021 | 105 | 0.270 |
Why?
| | Pediatrics | 2 | 2006 | 1101 | 0.270 |
Why?
| | Electronic Health Records | 6 | 2024 | 1069 | 0.270 |
Why?
| | Poverty | 5 | 2021 | 521 | 0.260 |
Why?
| | Community Health Services | 2 | 2010 | 227 | 0.260 |
Why?
| | Child Care | 1 | 2007 | 32 | 0.260 |
Why?
| | Measles | 2 | 2020 | 46 | 0.260 |
Why?
| | Internet | 1 | 2011 | 655 | 0.260 |
Why?
| | Accident Prevention | 1 | 2006 | 26 | 0.260 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5472 | 0.260 |
Why?
| | Child Development | 1 | 2011 | 475 | 0.260 |
Why?
| | Risk | 9 | 2017 | 912 | 0.250 |
Why?
| | Herpes Zoster | 2 | 2020 | 316 | 0.240 |
Why?
| | Stillbirth | 2 | 2024 | 72 | 0.240 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2017 | 25 | 0.240 |
Why?
| | Chorioamnionitis | 2 | 2017 | 42 | 0.240 |
Why?
| | International Classification of Diseases | 2 | 2020 | 135 | 0.230 |
Why?
| | Developmental Disabilities | 2 | 2020 | 263 | 0.230 |
Why?
| | Self Report | 3 | 2024 | 827 | 0.230 |
Why?
| | Aluminum | 2 | 2022 | 42 | 0.230 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2025 | 36 | 0.230 |
Why?
| | Athletic Injuries | 3 | 2006 | 529 | 0.220 |
Why?
| | Patient Acceptance of Health Care | 5 | 2024 | 806 | 0.220 |
Why?
| | Mass Screening | 2 | 2015 | 1287 | 0.220 |
Why?
| | Prenatal Care | 2 | 2017 | 294 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 128 | 0.210 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2014 | 99 | 0.210 |
Why?
| | Seasons | 6 | 2024 | 547 | 0.200 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 3 | 2022 | 250 | 0.200 |
Why?
| | Smallpox Vaccine | 1 | 2022 | 23 | 0.200 |
Why?
| | Multivariate Analysis | 4 | 2015 | 1509 | 0.200 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2021 | 261 | 0.190 |
Why?
| | Bell Palsy | 1 | 2022 | 7 | 0.190 |
Why?
| | Cataplexy | 1 | 2022 | 6 | 0.190 |
Why?
| | Narcolepsy | 1 | 2022 | 21 | 0.190 |
Why?
| | Pregnancy Outcome | 5 | 2025 | 416 | 0.190 |
Why?
| | Eczema | 1 | 2022 | 69 | 0.190 |
Why?
| | Thrombocytopenia | 2 | 2022 | 200 | 0.190 |
Why?
| | Healthcare Disparities | 2 | 2021 | 654 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 115 | 0.180 |
Why?
| | Premature Birth | 4 | 2024 | 333 | 0.180 |
Why?
| | Motivation | 2 | 2017 | 570 | 0.180 |
Why?
| | Pregnancy Complications | 3 | 2017 | 527 | 0.180 |
Why?
| | Disease Outbreaks | 1 | 2024 | 395 | 0.180 |
Why?
| | Fever | 2 | 2013 | 306 | 0.170 |
Why?
| | Risk Factors | 8 | 2020 | 10388 | 0.170 |
Why?
| | Databases, Factual | 4 | 2025 | 1357 | 0.170 |
Why?
| | Focus Groups | 2 | 2014 | 522 | 0.170 |
Why?
| | Vaccination Refusal | 1 | 2021 | 70 | 0.160 |
Why?
| | Mumps | 1 | 2020 | 25 | 0.160 |
Why?
| | Diphtheria-Tetanus Vaccine | 2 | 2009 | 4 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 804 | 0.160 |
Why?
| | Australia | 1 | 2020 | 315 | 0.160 |
Why?
| | Age Distribution | 4 | 2010 | 392 | 0.150 |
Why?
| | Sex Distribution | 4 | 2010 | 375 | 0.150 |
Why?
| | Tetanus Toxoid | 2 | 2015 | 35 | 0.150 |
Why?
| | Regression Analysis | 4 | 2015 | 1024 | 0.150 |
Why?
| | Aged | 8 | 2025 | 23961 | 0.140 |
Why?
| | Community Health Centers | 2 | 2009 | 60 | 0.140 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 15 | 0.140 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1313 | 0.140 |
Why?
| | Diagnosis, Oral | 1 | 2017 | 6 | 0.140 |
Why?
| | Paint | 1 | 2017 | 8 | 0.140 |
Why?
| | Syncope | 1 | 2017 | 52 | 0.140 |
Why?
| | Infant, Small for Gestational Age | 2 | 2015 | 92 | 0.140 |
Why?
| | Dentists | 1 | 2017 | 20 | 0.140 |
Why?
| | Confidence Intervals | 3 | 2021 | 329 | 0.140 |
Why?
| | Fluorides | 1 | 2017 | 49 | 0.130 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2017 | 42 | 0.130 |
Why?
| | Preconception Care | 1 | 2017 | 43 | 0.130 |
Why?
| | Prevalence | 4 | 2020 | 2734 | 0.130 |
Why?
| | Age Factors | 5 | 2017 | 3295 | 0.130 |
Why?
| | Logistic Models | 3 | 2015 | 2074 | 0.130 |
Why?
| | Drug Hypersensitivity | 1 | 2017 | 90 | 0.130 |
Why?
| | Registries | 4 | 2010 | 2035 | 0.130 |
Why?
| | Phosphates | 1 | 2017 | 182 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 1 | 2017 | 113 | 0.120 |
Why?
| | Educational Status | 2 | 2023 | 470 | 0.120 |
Why?
| | Time Factors | 9 | 2022 | 6828 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Causality | 2 | 2006 | 126 | 0.110 |
Why?
| | Sex Factors | 2 | 2021 | 2071 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 862 | 0.110 |
Why?
| | Health Care Surveys | 2 | 2007 | 565 | 0.110 |
Why?
| | Parental Consent | 1 | 2014 | 25 | 0.110 |
Why?
| | Fruit | 1 | 2015 | 140 | 0.110 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2014 | 28 | 0.110 |
Why?
| | Computer Simulation | 3 | 2013 | 978 | 0.110 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2014 | 69 | 0.110 |
Why?
| | Vegetables | 1 | 2015 | 157 | 0.110 |
Why?
| | Pandemics | 4 | 2024 | 1639 | 0.110 |
Why?
| | Patient Navigation | 1 | 2015 | 81 | 0.110 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2009 | 2031 | 0.100 |
Why?
| | Reimbursement Mechanisms | 1 | 2014 | 85 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2017 | 325 | 0.100 |
Why?
| | Social Environment | 1 | 2015 | 296 | 0.100 |
Why?
| | Drug Eruptions | 1 | 2013 | 27 | 0.100 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 101 | 0.100 |
Why?
| | Viral Vaccines | 1 | 2014 | 98 | 0.100 |
Why?
| | Comprehension | 1 | 2014 | 172 | 0.100 |
Why?
| | Rotavirus Infections | 2 | 2012 | 43 | 0.100 |
Why?
| | Utilization Review | 2 | 2009 | 36 | 0.100 |
Why?
| | Health Policy | 1 | 2016 | 388 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5131 | 0.100 |
Why?
| | Maternal Age | 2 | 2023 | 129 | 0.090 |
Why?
| | Health Services | 1 | 2013 | 107 | 0.090 |
Why?
| | Intussusception | 1 | 2012 | 28 | 0.090 |
Why?
| | Models, Theoretical | 2 | 2013 | 578 | 0.090 |
Why?
| | Health Education | 1 | 2015 | 341 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1289 | 0.090 |
Why?
| | Parenting | 1 | 2015 | 310 | 0.090 |
Why?
| | Electronic Mail | 1 | 2011 | 64 | 0.090 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.090 |
Why?
| | Database Management Systems | 1 | 2011 | 51 | 0.090 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 209 | 0.090 |
Why?
| | Health Care Costs | 1 | 2014 | 398 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 605 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2844 | 0.080 |
Why?
| | Qualitative Research | 1 | 2017 | 1386 | 0.080 |
Why?
| | Hepatitis A Vaccines | 1 | 2009 | 15 | 0.080 |
Why?
| | Diphtheria Toxoid | 1 | 2009 | 11 | 0.080 |
Why?
| | Altitude | 1 | 2014 | 488 | 0.080 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 45 | 0.080 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 5778 | 0.080 |
Why?
| | Asthma | 1 | 2022 | 2295 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 669 | 0.070 |
Why?
| | Patient Readmission | 1 | 2014 | 697 | 0.070 |
Why?
| | Drug Evaluation | 1 | 2008 | 84 | 0.070 |
Why?
| | Acetaminophen | 1 | 2011 | 268 | 0.070 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2008 | 4 | 0.070 |
Why?
| | Medicaid | 2 | 2009 | 435 | 0.070 |
Why?
| | Gastroenteritis | 1 | 2009 | 69 | 0.070 |
Why?
| | Ambulatory Care Facilities | 2 | 2009 | 232 | 0.070 |
Why?
| | Platelet Count | 1 | 2008 | 86 | 0.070 |
Why?
| | Splenectomy | 1 | 2008 | 62 | 0.070 |
Why?
| | Acute Disease | 2 | 2008 | 1007 | 0.070 |
Why?
| | House Calls | 1 | 2009 | 138 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 257 | 0.070 |
Why?
| | Probability | 1 | 2008 | 304 | 0.070 |
Why?
| | Communicable Disease Control | 1 | 2008 | 82 | 0.070 |
Why?
| | Vaccines, Conjugate | 2 | 2022 | 65 | 0.070 |
Why?
| | Health Surveys | 1 | 2009 | 514 | 0.070 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 310 | 0.060 |
Why?
| | Domestic Violence | 1 | 2006 | 53 | 0.060 |
Why?
| | Social Class | 1 | 2008 | 282 | 0.060 |
Why?
| | Chronic Disease | 2 | 2013 | 1793 | 0.060 |
Why?
| | Cluster Analysis | 2 | 2006 | 499 | 0.060 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2828 | 0.060 |
Why?
| | Skin | 1 | 2011 | 752 | 0.060 |
Why?
| | Patient Dropouts | 1 | 2006 | 67 | 0.060 |
Why?
| | Medication Adherence | 1 | 2009 | 467 | 0.060 |
Why?
| | Linear Models | 1 | 2008 | 849 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 338 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2008 | 1316 | 0.060 |
Why?
| | Disease Progression | 2 | 2014 | 2757 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3715 | 0.060 |
Why?
| | Accidents, Home | 1 | 2004 | 31 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1325 | 0.060 |
Why?
| | Pregnancy Trimester, First | 2 | 2017 | 140 | 0.060 |
Why?
| | Vaccines, Attenuated | 2 | 2017 | 132 | 0.060 |
Why?
| | Research Design | 2 | 2013 | 1139 | 0.060 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1171 | 0.060 |
Why?
| | Prospective Studies | 4 | 2021 | 7604 | 0.050 |
Why?
| | Hospitals, General | 1 | 2024 | 22 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2013 | 546 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2426 | 0.050 |
Why?
| | Physicians | 1 | 2012 | 910 | 0.050 |
Why?
| | Physicians, Family | 1 | 2005 | 201 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2015 | 7635 | 0.050 |
Why?
| | Public Health Informatics | 1 | 2003 | 10 | 0.050 |
Why?
| | Physician's Role | 1 | 2005 | 211 | 0.050 |
Why?
| | Health Status | 1 | 2008 | 792 | 0.050 |
Why?
| | Accidents, Traffic | 1 | 2004 | 190 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1266 | 0.050 |
Why?
| | Family Practice | 1 | 2007 | 464 | 0.050 |
Why?
| | Benchmarking | 1 | 2024 | 186 | 0.050 |
Why?
| | Respiratory Tract Infections | 1 | 2006 | 390 | 0.050 |
Why?
| | Thigh | 2 | 2013 | 48 | 0.050 |
Why?
| | Odds Ratio | 2 | 2015 | 1070 | 0.050 |
Why?
| | Injections, Intramuscular | 2 | 2013 | 129 | 0.050 |
Why?
| | Public Health Surveillance | 1 | 2021 | 82 | 0.040 |
Why?
| | Arm | 2 | 2013 | 104 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 126 | 0.040 |
Why?
| | Algorithms | 2 | 2020 | 1704 | 0.040 |
Why?
| | Myocarditis | 1 | 2021 | 100 | 0.040 |
Why?
| | Systole | 1 | 2020 | 189 | 0.040 |
Why?
| | Stroke | 1 | 2009 | 1120 | 0.040 |
Why?
| | Health Facilities | 1 | 2020 | 84 | 0.040 |
Why?
| | Antigens | 1 | 2021 | 357 | 0.040 |
Why?
| | Poisson Distribution | 2 | 2011 | 75 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 363 | 0.040 |
Why?
| | Mass Vaccination | 1 | 2019 | 16 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4030 | 0.040 |
Why?
| | Bias | 2 | 2013 | 218 | 0.040 |
Why?
| | Health Behavior | 2 | 2015 | 762 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 1587 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 516 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 910 | 0.040 |
Why?
| | Exercise | 2 | 2020 | 2057 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2020 | 625 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 294 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2833 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2015 | 28 | 0.030 |
Why?
| | Computers | 1 | 2015 | 70 | 0.030 |
Why?
| | Video Games | 1 | 2015 | 27 | 0.030 |
Why?
| | Refugees | 1 | 2015 | 75 | 0.030 |
Why?
| | Demography | 1 | 2015 | 291 | 0.030 |
Why?
| | Television | 1 | 2015 | 75 | 0.030 |
Why?
| | Vasculitis | 1 | 2014 | 66 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 786 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 90 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1786 | 0.030 |
Why?
| | Emigrants and Immigrants | 1 | 2015 | 136 | 0.030 |
Why?
| | Family Characteristics | 1 | 2015 | 191 | 0.030 |
Why?
| | California | 1 | 2014 | 431 | 0.030 |
Why?
| | Drug Utilization | 1 | 2013 | 169 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2015 | 272 | 0.020 |
Why?
| | Monitoring, Immunologic | 1 | 2011 | 25 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 199 | 0.020 |
Why?
| | Sample Size | 1 | 2011 | 125 | 0.020 |
Why?
| | Family | 1 | 2015 | 671 | 0.020 |
Why?
| | Schools | 1 | 2014 | 461 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 558 | 0.020 |
Why?
| | Safety Management | 1 | 2011 | 124 | 0.020 |
Why?
| | Data Collection | 1 | 2013 | 673 | 0.020 |
Why?
| | Safety | 1 | 2011 | 338 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 992 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 97 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 786 | 0.020 |
Why?
| | Diet | 1 | 2015 | 1278 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2057 | 0.010 |
Why?
| | Health Care Reform | 1 | 2005 | 107 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1946 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 2005 | 273 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1477 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3284 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 10811 | 0.010 |
Why?
|
|
Hambidge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|